Anteris Technologies Global Corp. Common Stock (AVR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) has a cash flow conversion efficiency ratio of -5.434x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.25 Million) by net assets ($3.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anteris Technologies Global Corp. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Anteris Technologies Global Corp. Common carry for a breakdown of total debt and financial obligations.
Anteris Technologies Global Corp. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anteris Technologies Global Corp. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NRC Group ASA
OL:NRC
|
0.048x |
|
China Silver Group Limited
F:2CS
|
0.013x |
|
Punjab Chemicals & Crop Protection Limited
NSE:PUNJABCHEM
|
0.207x |
|
E-Life Mall Corp
TW:6281
|
0.110x |
|
Grigeo AB
STU:WM8
|
0.073x |
|
CHOROKBAEM COMPANY Co. Ltd
KQ:052300
|
0.032x |
|
Tofu Restaurant Co Ltd
TWO:2752
|
0.148x |
|
POLARIS RENEWABLE ENERGY
F:N4T
|
N/A |
Annual Cash Flow Conversion Efficiency for Anteris Technologies Global Corp. Common Stock (2020–2024)
The table below shows the annual cash flow conversion efficiency of Anteris Technologies Global Corp. Common Stock from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see AVR market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $62.68 Million | $-61.24 Million | -0.977x | +46.69% |
| 2023-12-31 | $18.90 Million | $-34.63 Million | -1.833x | +43.73% |
| 2022-12-31 | $9.03 Million | $-29.42 Million | -3.257x | -137.39% |
| 2021-12-31 | $10.52 Million | $-14.44 Million | -1.372x | +77.03% |
| 2020-12-31 | $1.86 Million | $-11.08 Million | -5.971x | -- |
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more